We are live on !
Find out more
BlackBarn Capital Partners Portfolio holdings
AUM
$1.19B
Turnover
50%
1-Year Est. Return
63.92%
This Fund
S&P 500
This Quarter Est. Return
+14.84%
1 Year Est. Return
+63.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.19B
AUM Growth
-$57.7M
(-4.6%)
Cap. Flow
+$37.1M
Cap. Flow % of AUM
Cap. Flow %
3.13%
Top 10 Holdings %
Top 10 Hldgs %
81.6%
Holding
30
New
9
Increased
3
Reduced
7
Closed
6
Avg Time Held
Equity + Options
0.8
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.9
years
Avg Time Held Equity only
1
year
Top 10 Avg Time Held Equity only
1.1
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$24.1M |
| 2 |
Venture Global Inc
VG
|
+$22.1M |
| 3 |
Azul S.A.
AZUL
|
+$14.9M |
| 4 |
Occidental Petroleum
OXY
|
+$14.2M |
| 5 |
California Resources
CRC
|
+$10.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veeco
VECO
|
+$33.9M |
| 2 |
American Express Global Business Travel
GBTG
|
+$11.2M |
| 3 |
Roivant Sciences
ROIV
|
+$8.43M |
| 4 |
Diversified Healthcare Trust
DHC
|
+$6.04M |
| 5 |
Amneal Pharmaceuticals
AMRX
|
+$4.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 69.27% |
| 2 | Healthcare | 16.58% |
| 3 | Technology | 4.42% |
| 4 | Energy | 3.45% |
| 5 | Utilities | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$820B
| $597M | 50.4% |
800,000
| – | – |
2024 Q3
7 quarters
|
|
|
2
Roivant Sciences
ROIV
$26.8B
| $70.8M | 5.97% |
2,000,000
-285,117
| -12% | -$8.43M |
2023 Q4
10 quarters
|
|
3
PUT
Oscar Health
OSCR
$9.41B
| $49.9M | 4.21% |
+1,750,000
| New | +$37.7M |
2026 Q2
0 quarters
|
|
|
4
CALL
UnitedHealth
UNH
$365B
| $41.6M | 3.51% |
+100,000
| New | +$37.1M |
2026 Q2
0 quarters
|
|
5
Privia Health
PRVA
$2.79B
| $40.8M | 3.44% |
1,585,000
| – | – |
2023 Q4
10 quarters
|
|
6
PUT
ResMed
RMD
$35.2B
| $39M | 3.29% |
200,000
-200,000
| -50% | -$41.5M |
2025 Q3
3 quarters
|
|
|
7
Diversified Healthcare Trust
DHC
$1.89B
| $37.9M | 3.2% |
4,075,000
-737,413
| -15% | -$6.04M |
2023 Q4
10 quarters
|
|
|
8
CALL
Venture Global Inc
VG
$35.9B
| $33.4M | 2.82% |
+3,000,000
| New | +$38M |
2026 Q2
0 quarters
|
|
9
NextEra Energy
NEE
$170B
| $29.4M | 2.48% |
335,000
| – | – |
2025 Q2
4 quarters
|
|
10
NIQ Global Intelligence PLC
NIQ
$5.93B
| $27.2M | 2.29% |
2,903,862
+829,101
| +40% | +$8.02M |
2025 Q4
2 quarters
|
|
|
11
UnitedHealth
UNH
$365B
| $27M | 2.28% |
+65,000
| New | +$24.1M |
2026 Q2
0 quarters
|
|
12
NXP Semiconductors
NXPI
$63.4B
| $25.3M | 2.13% |
90,000
+30,000
| +50% | +$8.27M |
2026 Q1
1 quarter
|
|
13
Viking Therapeutics
VKTX
$3.22B
| $23.4M | 1.97% |
600,000
-21,450
| -3% | -$693K |
2025 Q2
4 quarters
|
|
14
McGraw Hill
MH
$2.61B
| $23.2M | 1.96% |
2,450,000
+361,508
| +17% | +$4.36M |
2025 Q3
3 quarters
|
|
|
15
Amneal Pharmaceuticals
AMRX
$7.36B
| $22.5M | 1.9% |
1,300,000
-350,000
| -21% | -$4.8M |
2024 Q1
9 quarters
|
|
|
16
Venture Global Inc
VG
$35.9B
| $19.5M | 1.64% |
+1,750,000
| New | +$22.1M |
2026 Q2
0 quarters
|
|
|
17
Azul S.A.
AZUL
$756M
| $15.1M | 1.28% |
+1,684,188
| New | +$14.9M |
2026 Q2
0 quarters
|
|
|
18
Occidental Petroleum
OXY
$62.8B
| $12.1M | 1.02% |
+250,000
| New | +$14.2M |
2026 Q2
0 quarters
|
|
19
PUT
Warby Parker
WRBY
$3.02B
| $12.1M | 1.02% |
400,000
-600,000
| -60% | -$14.9M |
2025 Q3
3 quarters
|
|
20
Arbutus Biopharma
ABUS
$856M
| $12M | 1.01% |
2,500,000
| – | – |
2024 Q1
9 quarters
|
|
|
21
CALL
Viking Therapeutics
VKTX
$3.22B
| $9.8M | 0.82% |
+250,000
| New | +$8.08M |
2026 Q2
0 quarters
|
|
|
22
California Resources
CRC
$4.86B
| $9.25M | 0.78% |
+175,000
| New | +$10.8M |
2026 Q2
0 quarters
|
|
23
Cogent Communications
CCOI
$391M
| $3.47M | 0.29% |
250,000
-250,000
| -50% | -$4.61M |
2025 Q1
5 quarters
|
|
24
Vivid Seats
SEAT
$26.1M
| $3.26M | 0.28% |
500,000
| – | – |
2026 Q1
1 quarter
|
|
25
PUT
American Airlines Group
AAL
$8.34B
| – | – |
-4,000,000
| Closed | -$43M | – |
|
Similar funds
GA
MI
BlackBarn Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, BlackBarn Capital Partners held 30 positions worth $1.19B, down 4.6% from $1.24B the previous quarter. Its ten largest holdings account for 82% of the portfolio.
BlackBarn Capital Partners deployed $37.1M of net new capital in Q2 2026, opening 9 new positions and adding to 3 existing holdings. Its largest new stake was UnitedHealth: 65,000 shares worth $27M.
By sector, the portfolio is most concentrated in Miscellaneous at 69% of assets, down from 76% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Roivant Sciences, an estimated $8.43M trimmed.
- BlackBarn Capital Partners's largest Q2 2026 buy was UnitedHealth: 65,000 shares worth $27M.
- BlackBarn Capital Partners added most to NXP Semiconductors in Q2 2026, an estimated $8.27M increase.
- BlackBarn Capital Partners's biggest Q2 2026 reduction was Roivant Sciences, cutting an estimated $8.43M.
- BlackBarn Capital Partners fully exited Veeco in Q2 2026, selling an estimated $33.9M.
- BlackBarn Capital Partners's ten largest holdings make up 82% of its $1.19B portfolio in Q2 2026.
- BlackBarn Capital Partners opened 9 new positions and closed 6 in Q2 2026.
- BlackBarn Capital Partners's portfolio value fell 4.6% quarter-over-quarter to $1.19B.
Based on BlackBarn Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.